Market Tracker

11/17 5:15pm ET

Myriad Genetics Inc (NASDAQ:MYGN)

32.88
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
15.15
Today|||52-Week Range
37.30
+97.24%
Year-to-Date

Today’s Trading

Previous close32.88
Today’s open33.21
Day’s range32.44 - 33.37
Volume956,880
Average volume (3 months)1,039,273
Market cap$2.3B
Dividend yield--
Data as of 4:00pm ET, 11/17/2017

Growth & Valuation

Earnings growth (last year)-81.29%
Earnings growth (this year)-0.51%
Earnings growth (next 5 years)+9.30%
Revenue growth (last year)+2.33%
P/E ratio22.1
Price/Sales2.30
Price/Book2.94

Competitors

 Today’s
change
Today’s
% change
AAAPAdvanced Accelerator...0.000.00%
NEOGNeogen Corp0.000.00%
IMMUImmunomedics Inc0.000.00%
QDELQuidel Corp0.000.00%
Data as of 4:00pm ET, 11/17/2017

Financials

Next reporting dateFebruary 6, 2018
EPS forecast (this quarter)$0.24
Annual revenue (last year)$771.4M
Annual profit (last year)$21.8M
Net profit margin2.83%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark C. Capone
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts